Comprehensive Analysis of the Biologics Testing Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the biologics testing market right now?
There has been a swift expansion in the biologics testing market over recent years. The market which currently stands at $5.92 billion in 2024 is expected to escalate to $6.85 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 15.7%. The noteworthy growth observed in the past years is attributable to factors such as developments in biologics, strict regulatory norms, quality control advancements in bioprocessing, increased investments in biopharmaceuticals, and the expansion of biomanufacturing capacity.
How fast Is the biologics testing market expected to grow, and what’s its future value?
The biologics testing market is projected to experience notable expansion in the coming years, surging to “$12.91 billion by 2029 with a compound annual growth rate (CAGR) of 17.2%. The impressive growth throughout the prediction period is a result of the emergence of innovative therapies, heightened demand for contract testing services, the expansion of biologics pipelines, the globalization of biopharmaceutical manufacturing, coupled with a growing need for fast testing solutions. The forecast period will also witness trending advancements in analytical technology, cell-based assays, next-generation sequencing (NGS), principles of quality by design (QBD), integration with artificial intelligence (AI), and swift methods for product release.
Get your biologics testing market report here!
https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report
What are the leading drivers of growth in the biologics testing market?
The swift expansion of the pharmaceutical and biotechnology industries is set to further drive the growth of the biologics testing market. The focus of the pharmaceutical industry lies primarily in the development and production of varied medications to treat multiple diseases and health conditions. Conversely, the biotechnology industry applies technology to biology and healthcare. Biologics testing encompasses tests to detect and measure impurities, evaluate stability, and gauge the immune response to the drug. Innovation in biologics testing technology, courtesy of the pharmaceutical and biotechnology industries’ growth, has led to state-of-the-art analytical tools and techniques. This innovation results in more precise and effective testing, decreasing the time and cost to launch new biologics in the market. For instance, Eurostat, a Belgium-based governing body, reported in July 2024 that pharmaceutical production in the EU jumped from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating robust sector growth. Consequently, the fast-paced growth of the pharmaceutical and biotechnology industries is propelling the biologics testing market’s expansion.
What are the key segments defining the biologics testing market?
The biologics testing market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Other Products
2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types
3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications
Subsegments:
1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents, Other Assay Kits
2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers, Other Analytical Instruments
3) By Other Products: Software, Consumables, Reference Standards
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp
Who are the key players steering the development of the biologics testing market?
Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.
What emerging trends are influencing the growth of the biologics testing market?
The emergence of product innovations is a key event happening within the biologics testing market. Firms within this market are utilizing newly created, innovative products to maintain their standing. As an example, in December 2022, Charles River Laboratories International, Inc., a US-based contract research firm specializing in non-clinical fields, introduced Endosafe Nexus 200. This addition expands their existing endotoxin testing line. The Nexus 200, a fully robotic instrument incorporating data integrity compliance, represents the future direction of Charles River. Employing Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology, it is able to manage simple or complex dilutions for water, in-process, and end product testing. The system operates on Endosafe EndoScan-V version 6.1, allowing data to be transferred to a Laboratory Information Management System (LIMS) interface. This provides improved traceability, security, and data management via an integrated touch screen.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276
Which regions are most influential in expanding the biologics testing market?
North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Tank Wagons Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tank-wagons-global-market-report
Bag-in-box Containers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bag-in-box-containers-global-market-report
Boiler, Tank, And Shipping Container Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
